Stock NVNO ENVVENO MEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus enVVeno Medical Corporation

Equities

NVNO

US29415J1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
5.22 USD +0.77% Intraday chart for enVVeno Medical Corporation +6.31% +1.56%
Apr. 16 EnVVeno Medical Corporation Announces Additional Topline Efficacy Data from the VenoValve U.S. Pivotal Trial to Be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 CI
Apr. 09 EnVVeno Medical Corporation Appoints Andrew Cormack as Its Chief Commercial Officer CI

Evolution of the average Target Price on enVVeno Medical Corporation

Price target over the last 5 years

History of analyst recommendation changes

4b2517f2ee342.jIBn532w4A8p3C9FROCpNGowieR41zi6qA62fXagarg.5OcskBDkpkhnk10rNrTcWSF_38kyuGL9nHzXJzTvAtb-0DKuE-aaNkaeTA~cde70e6985e9f63ef6bb3bb2b5d8d4ac

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.18 USD
Average target price
20.4 USD
Spread / Average Target
+293.82%
High Price Target
20.4 USD
Spread / Highest target
+293.82%
Low Price Target
20.4 USD
Spread / Lowest Target
+293.82%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NVNO Stock
  4. Consensus enVVeno Medical Corporation